These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 14623547)

  • 1. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
    Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen metabolites and breast cancer.
    Santen RJ; Yue W; Wang JP
    Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen versus aromatase inhibitors for breast cancer prevention.
    Yue W; Wang JP; Li Y; Bocchinfuso WP; Korach KS; Devanesan PD; Rogan E; Cavalieri E; Santen RJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):925s-30s. PubMed ID: 15701888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors.
    Devanesan P; Santen RJ; Bocchinfuso WP; Korach KS; Rogan EG; Cavalieri E
    Carcinogenesis; 2001 Sep; 22(9):1573-6. PubMed ID: 11532882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
    Santen R; Cavalieri E; Rogan E; Russo J; Guttenplan J; Ingle J; Yue W
    Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
    Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
    Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
    Cavalieri E; Rogan E
    Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
    Yager JD
    Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of aromatase inhibitors in breast cancer prevention.
    Santen RJ; Yue W; Naftolin F; Mor G; Berstein L
    Endocr Relat Cancer; 1999 Jun; 6(2):235-43. PubMed ID: 10731115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
    Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Yue W; Berstein L
    Endocr Relat Cancer; 2003 Jun; 10(2):111-30. PubMed ID: 12790774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
    Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
    Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
    Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
    J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors.
    Cavalieri EL; Kumar S; Todorovic R; Higginbotham S; Badawi AF; Rogan EG
    Chem Res Toxicol; 2001 Aug; 14(8):1041-50. PubMed ID: 11511178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
    Russo J; Hasan Lareef M; Balogh G; Guo S; Russo IH
    J Steroid Biochem Mol Biol; 2003 Oct; 87(1):1-25. PubMed ID: 14630087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.
    Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG
    J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
    Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms.
    Yue W; Wang JP; Li Y; Fan P; Liu G; Zhang N; Conaway M; Wang H; Korach KS; Bocchinfuso W; Santen R
    Int J Cancer; 2010 Oct; 127(8):1748-57. PubMed ID: 20104523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.